Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)
Close on Nov 17, 2026Market cap $545.36KP/E –Yield –
Clearmind Medicine price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Clearmind Medicine
Clearmind Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?